Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000116366 | SCV000150290 | uncertain significance | not provided | 2014-03-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000460419 | SCV000551583 | uncertain significance | Spastic paraplegia | 2024-01-08 | criteria provided, single submitter | clinical testing | This sequence change replaces histidine, which is basic and polar, with asparagine, which is neutral and polar, at codon 205 of the AP4E1 protein (p.His205Asn). This variant is present in population databases (rs148499164, gnomAD 0.07%). This missense change has been observed in individual(s) with persistent stutter (PMID: 26544806). ClinVar contains an entry for this variant (Variation ID: 128402). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change does not substantially affect AP4E1 function (PMID: 26544806). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV000763973 | SCV000894924 | uncertain significance | Stuttering, familial persistent, 1; Hereditary spastic paraplegia 51 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000116366 | SCV001714524 | uncertain significance | not provided | 2021-12-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000116366 | SCV001747128 | uncertain significance | not provided | 2021-06-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000116366 | SCV001773825 | uncertain significance | not provided | 2021-04-27 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26544806) |
Genome Diagnostics Laboratory, |
RCV001847663 | SCV002105217 | uncertain significance | Hereditary spastic paraplegia | 2019-09-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002514584 | SCV003606746 | uncertain significance | Inborn genetic diseases | 2024-05-07 | criteria provided, single submitter | clinical testing | (Grozeva, 2015) Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |